U.S. markets closed
  • S&P Futures

    3,255.75
    +17.75 (+0.55%)
     
  • Dow Futures

    26,855.00
    +140.00 (+0.52%)
     
  • Nasdaq Futures

    10,953.00
    +61.25 (+0.56%)
     
  • Russell 2000 Futures

    1,460.80
    +13.80 (+0.95%)
     
  • Crude Oil

    40.55
    +0.24 (+0.60%)
     
  • Gold

    1,872.20
    -4.70 (-0.25%)
     
  • Silver

    23.18
    -0.01 (-0.05%)
     
  • EUR/USD

    1.1671
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    0.6660
    -0.0100 (-1.48%)
     
  • Vix

    28.51
    -0.07 (-0.24%)
     
  • GBP/USD

    1.2758
    +0.0006 (+0.04%)
     
  • USD/JPY

    105.4760
    +0.0740 (+0.07%)
     
  • BTC-USD

    10,712.73
    -47.86 (-0.44%)
     
  • CMC Crypto 200

    218.44
    +9.50 (+4.55%)
     
  • FTSE 100

    5,822.78
    -76.48 (-1.30%)
     
  • Nikkei 225

    23,221.40
    +133.58 (+0.58%)
     

CooperCompanies to Participate in the Morgan Stanley Virtual Global Healthcare Conference

The Cooper Companies, Inc.

SAN RAMON, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 2020. Brian Andrews, Senior Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 2:45 pm ET.

A webcast of the session will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com